leflunomide has been researched along with Cystitis in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
Excerpt | Relevance | Reference |
---|---|---|
"Leflunomide, an immunosuppressant with antiviral activity, was used to treat 5 children with severe BK virus-associated hemorrhagic cystitis after hematopoietic stem cell transplantation." | 7.80 | Effective treatment of severe BK virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study. ( Chao, YH; Peng, CT; Sheu, JN; Weng, T; Wu, HP; Wu, KH, 2014) |
"Leflunomide is an immunosuppressive drug with antiviral activity and has been used in treating BKV-associated nephropathy after renal transplantation." | 5.39 | Efficacy and safety of leflunomide for the treatment of BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. ( Chen, XC; He, C; Huang, R; Li, JJ; Liu, T; Meng, WT, 2013) |
"Leflunomide, an immunosuppressant with antiviral activity, was used to treat 5 children with severe BK virus-associated hemorrhagic cystitis after hematopoietic stem cell transplantation." | 3.80 | Effective treatment of severe BK virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study. ( Chao, YH; Peng, CT; Sheu, JN; Weng, T; Wu, HP; Wu, KH, 2014) |
"Leflunomide is an immunosuppressive drug with antiviral activity and has been used in treating BKV-associated nephropathy after renal transplantation." | 1.39 | Efficacy and safety of leflunomide for the treatment of BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. ( Chen, XC; He, C; Huang, R; Li, JJ; Liu, T; Meng, WT, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XC | 1 |
Liu, T | 1 |
Li, JJ | 1 |
He, C | 1 |
Meng, WT | 1 |
Huang, R | 1 |
Wu, KH | 1 |
Weng, T | 1 |
Wu, HP | 1 |
Peng, CT | 1 |
Sheu, JN | 1 |
Chao, YH | 1 |
2 other studies available for leflunomide and Cystitis
Article | Year |
---|---|
Efficacy and safety of leflunomide for the treatment of BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients.
Topics: Adult; BK Virus; Cystitis; Enzyme Inhibitors; Female; Hematopoietic Stem Cell Transplantation; Hemor | 2013 |
Effective treatment of severe BK virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study.
Topics: Adolescent; BK Virus; Child; Cystitis; Female; Hematopoietic Stem Cell Transplantation; Hematuria; H | 2014 |